Skip to main content

Hitachi to Deliver Response Genetics’ Clinical Sample Testing Tech in Asia-Pacific

NEW YORK (GenomeWeb News) - Response Genetics today said it has struck an agreement with Hitachi Chemical that will allow Hitachi to use its genetic diagnostic testing methods and services for formalin-fixed paraffin-embedded tissue samples in Southeast Asia, Australia, and New Zealand. 
 
Hitachi will also give Response Genetics access to “potential new testing services customers” in Asia for its FFPE clinical sample testing technology, the company said.
 
Response Genetics said it will provide Hitachi with technical information and assistance related to its testing services and the two companies will split the revenues that come from the collaboration.
 
The countries the partnership covers include Japan, North Korea, South Korea, Taiwan, Mongolia, Pakistan, Bangladesh, Sri Lanka, Nepal, Singapore, Malaysia, Indonesia, Brunei, Thailand, Myanmar, Laos, Cambodia, Vietnam, and the Philippines.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.